Page last updated: 2024-11-05

thiotepa and Hormone-Dependent Neoplasms

thiotepa has been researched along with Hormone-Dependent Neoplasms in 2 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pegram, M1
Hsu, S1
Lewis, G1
Pietras, R1
Beryt, M1
Sliwkowski, M1
Coombs, D1
Baly, D1
Kabbinavar, F1
Slamon, D1
Elias, AD1
Ibrahim, J1
Richardson, P1
Avigan, D1
Joyce, R1
Reich, E1
McCauley, M1
Wheeler, C1
Frei, E1

Trials

1 trial available for thiotepa and Hormone-Dependent Neoplasms

ArticleYear
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farbe
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2002, Volume: 8, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carcinoma; Com

2002

Other Studies

1 other study available for thiotepa and Hormone-Dependent Neoplasms

ArticleYear
Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Oncogene, 1999, Apr-01, Volume: 18, Issue:13

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal

1999